The alpha-fetoprotein third domain receptor binding fragment: in search of scavenger and associated receptor targets.

Abstract:

:Recent studies have demonstrated that the carboxyterminal third domain of alpha-fetoprotein (AFP-CD) binds with various ligands and receptors. Reports within the last decade have established that AFP-CD contains a large fragment of amino acids that interact with several different receptor types. Using computer software specifically designed to identify protein-to-protein interaction at amino acid sequence docking sites, the computer searches identified several types of scavenger-associated receptors and their amino acid sequence locations on the AFP-CD polypeptide chain. The scavenger receptors (SRs) identified were CD36, CD163, Stabilin, SSC5D, SRB1 and SREC; the SR-associated receptors included the mannose, low-density lipoprotein receptors, the asialoglycoprotein receptor, and the receptor for advanced glycation endproducts (RAGE). Interestingly, some SR interaction sites were localized on the AFP-derived Growth Inhibitory Peptide (GIP) segment at amino acids #480-500. Following the detection studies, a structural subdomain analysis of both the receptor and the AFP-CD revealed the presence of epidermal growth factor (EGF) repeats, extracellular matrix-like protein regions, amino acid-rich motifs and dimerization subdomains. For the first time, it was reported that EGF-like sequence repeats were identified on each of the three domains of AFP. Thereafter, the localization of receptors on specific cell types were reviewed and their functions were discussed.

journal_name

J Drug Target

authors

Mizejewski GJ

doi

10.3109/1061186X.2015.1015538

subject

Has Abstract

pub_date

2015-01-01 00:00:00

pages

538-51

issue

6

eissn

1061-186X

issn

1029-2330

journal_volume

23

pub_type

杂志文章,评审
  • Lactose-modified DNA tile nanostructures as drug carriers.

    abstract:BACKGROUND:DNA hybridization allows the preparation of nanoscale DNA structures with desired shape and size. DNA structures using simple base pairing can be used for the delivery of drug molecules into the cells. Since DNA carries multiple negative charges, their cellular uptake efficiency is low. Thus, the modificatio...

    journal_title:Journal of drug targeting

    pub_type: 杂志文章

    doi:10.3109/1061186X.2016.1144059

    authors: Akkus Sut P,Tunc CU,Culha M

    更新日期:2016-09-01 00:00:00

  • EGFR-targeted immunoliposomes derived from the monoclonal antibody EMD72000 mediate specific and efficient drug delivery to a variety of colorectal cancer cells.

    abstract::We hypothesized that immunoliposomes (ILs) constructed using Fab' from the humanized anti-EGFR monoclonal antibody, EMD72000, can provide efficient intracellular drug delivery in EGFR-overexpressing colorectal tumor cells.ILs were constructed modularly with various MAb fragments, including Fab' from EMD72000 (matuzuma...

    journal_title:Journal of drug targeting

    pub_type: 杂志文章

    doi:10.1080/10611860600691049

    authors: Mamot C,Ritschard R,Küng W,Park JW,Herrmann R,Rochlitz CF

    更新日期:2006-05-01 00:00:00

  • Oridonin-loaded poly(epsilon-caprolactone)-poly(ethylene oxide)-poly(epsilon-caprolactone) copolymer nanoparticles: preparation, characterization, and antitumor activity on mice with transplanted hepatoma.

    abstract::The aim of the present study was to develop a polymeric delivery system for water-insoluble drug oridonin. Amphiphilic block copolymers, poly(epsilon-caprolactone)-poly(ethylene glycol)-poly (epsilon-caprolactone) (PCL-PEO-PCL), were synthesized by ring-opening polymerization of caprolactone initiated by the hydroxyl ...

    journal_title:Journal of drug targeting

    pub_type: 杂志文章

    doi:10.1080/10611860802200938

    authors: Feng N,Wu P,Li Q,Mei Y,Shi S,Yu J,Xu J,Liu Y,Wang Y

    更新日期:2008-07-01 00:00:00

  • siRNA: an alternative treatment for diabetes and associated conditions.

    abstract::Diabetes is a condition that is not completely treatable but life of a diabetic patient can be smoothed by preventing or delaying the associate conditions like diabetic retinopathy, nephropathy, impaired wound healing process, etc. Apart from conventional methods to regulate diabetic condition, new techniques using si...

    journal_title:Journal of drug targeting

    pub_type: 杂志文章,评审

    doi:10.1080/1061186X.2018.1476518

    authors: Shende P,Patel C

    更新日期:2019-02-01 00:00:00

  • Ultrasound enhancement of in vitro transfection of plasmid DNA by a cationized gelatin.

    abstract::In vitro transfection efficiency of a plasmid DNA for rat gastric mucosal (RGM)-1 cells was enhanced by ultrasound (US) irradiation. Ethylenediamine was introduced to the carboxyl groups of gelatin to prepare a cationized gelatin as the vector of plasmid DNA encoding luciferase. An electrophoresis experiment revealed ...

    journal_title:Journal of drug targeting

    pub_type: 杂志文章,收录出版

    doi:10.1080/10611860290022624

    authors: Hosseinkhani H,Aoyama T,Ogawa O,Tabata Y

    更新日期:2002-05-01 00:00:00

  • The anti-tumor effect of folate-targeted liposome microbubbles loaded with oridonin as ultrasound-triggered tumor-targeted therapeutic carrier system.

    abstract::In this study, folate receptor (FR) targeted liposome microbubbles loaded with oridonin (ORI) (F-LMB-ORI), liposome loaded with ORI (L-ORI) and liposome microbubbles loaded with ORI (LMB-ORI) were prepared. In vitro release properties, cellular uptake and cytotoxicity in HepG-2 cells as well as in vivo antitumor effec...

    journal_title:Journal of drug targeting

    pub_type: 杂志文章

    doi:10.1080/1061186X.2016.1200588

    authors: Wang C,Li W,Hu B

    更新日期:2017-01-01 00:00:00

  • Multifunctional radiolabeled nanoparticles: strategies and novel classification of radiopharmaceuticals for cancer treatment.

    abstract::In this review, we emphasize the efforts on the development of radiolabeled nanoparticles (NPs) for cancer treatment, i.e. theranostic tools based on nanotechnology and nuclear medicine. Currently, radionuclide therapy remains to be an important treatment option. The ionizing radiation from radionuclides (not provided...

    journal_title:Journal of drug targeting

    pub_type: 杂志文章,评审

    doi:10.3109/1061186X.2014.988216

    authors: Enrique MA,Mariana OR,Mirshojaei SF,Ahmadi A

    更新日期:2015-04-01 00:00:00

  • Cascade catalytic nanoplatform for enhanced starvation and sonodynamic therapy.

    abstract::Background: Sonodynamic therapy (SDT) has emerged as an alternative to the traditional treatments of cancer. However, the oxygen consumption induced by SDT and glucose oxidase (GOx) mediated starvation therapy would worsen the hypoxic tumor environment, which further impeded therapeutic efficacy. Purpose: To develop a...

    journal_title:Journal of drug targeting

    pub_type: 杂志文章

    doi:10.1080/1061186X.2019.1641507

    authors: Zhang Y,Wang H,Jia X,Du S,Yin Y,Zhang X

    更新日期:2020-02-01 00:00:00

  • Malaria treatment using novel nano-based drug delivery systems.

    abstract::We reside in an era of technological innovation and advancement despite which infectious diseases like malaria remain to be one of the greatest threats to the humans. Mortality rate caused by malaria disease is a huge concern in the twenty-first century. Multiple drug resistance and nonspecific drug targeting of the m...

    journal_title:Journal of drug targeting

    pub_type: 杂志文章,评审

    doi:10.1080/1061186X.2017.1291645

    authors: Baruah UK,Gowthamarajan K,Vanka R,Karri VVSR,Selvaraj K,Jojo GM

    更新日期:2017-08-01 00:00:00

  • Development of a novel drug delivery system, time-controlled explosion system (TES). IV. In vivo drug release behavior.

    abstract::Time-Controlled Explosion System (TES) has the time-controlled drug release property with a pre-designed lag time. The drug release from the system is initiated by destruction of the membrane. In this study, metoprolol tartrate was used as a model drug. After five types of TES with different in vitro lag times were or...

    journal_title:Journal of drug targeting

    pub_type: 杂志文章

    doi:10.3109/10611869409015901

    authors: Ueda S,Ibuki R,Kawamura A,Murata S,Takahashi T,Kimura S,Hata T

    更新日期:1994-01-01 00:00:00

  • Low-intensity light-induced paclitaxel release from lipid-based nano-delivery systems.

    abstract::Light-induced drug release has been explored as a strategy for externally modulating the release of drug from delivery systems. This study reports the development of a solid lipid nanoparticulate system (SLN) for paclitaxel (PTX), where photosensitizer-mediated oxidation of lipids was used as a mechanism for controlli...

    journal_title:Journal of drug targeting

    pub_type: 杂志文章

    doi:10.1080/1061186X.2019.1571066

    authors: Meerovich I,Nichols MG,Dash AK

    更新日期:2019-11-01 00:00:00

  • Topical delivery of TRPsiRNA-loaded solid lipid nanoparticles confer reduced pain sensation via TRPV1 silencing, in rats.

    abstract::Present work describes a novel composition for encapsulating TRPsiRNA (TRPV1-targeting siRNA) within lipid-matrix (4:1::glyceryl behnate:stearic acid) of SLNs, using suitably modified cold high-pressure homogenisation technique. Optimisation of the method and composition conducted using calf-thymus DNA (ctDNA), to avo...

    journal_title:Journal of drug targeting

    pub_type: 杂志文章

    doi:10.1080/1061186X.2017.1350857

    authors: Sharma G,Chopra K,Puri S,Bishnoi M,Rishi P,Kaur IP

    更新日期:2018-02-01 00:00:00

  • Targeting of doxorubicin to the urinary bladder of the rat shows increased cytotoxicity in the bladder urine combined with an absence of renal toxicity.

    abstract::Targeting of anti-tumor drugs to the urinary bladder for the treatment of bladder carcinoma may be useful, since these agents generally have a low degree of urinary excretion and are highly toxic elsewhere in the body. The anti-tumor drug doxorubicin was coupled to the low-molecular weight protein lysozyme via the aci...

    journal_title:Journal of drug targeting

    pub_type: 杂志文章

    doi:10.1080/10611860290007568

    authors: Haas M,Moolenaar F,Elsinga A,Van der Wouden EA,de Jong PE,Meijer DK,de Zeeuw D

    更新日期:2002-02-01 00:00:00

  • Phospholipids-based ultrasonic microbubbles for catechins encapsulation and ultrasound-triggered release.

    abstract:OBJECTIVE:The objective of this work was to examine the application of catechins-containing phospholipids-based ultrasonic microbubbles (PUM) in ultrasound-induced delivery. METHODS:Catechins-containing PUM were prepared by dissolving lyophilized PUM powder in catechins solution. Morphologic characteristics of catechi...

    journal_title:Journal of drug targeting

    pub_type: 杂志文章

    doi:10.1080/10611860802475696

    authors: Lu CT,Zhao YZ

    更新日期:2008-12-01 00:00:00

  • Pharmacokinetics and targeting property of TFu-loaded liposomes with different sizes after intravenous and oral administration.

    abstract::The purpose of the study was to develop the liposomal formulations of TFu for oral and intravenous (i.v.) administration, clarify the biodistribution characteristics and in vivo pharmacokinetic behaviors of TFu-loaded liposomes. Four TFu-loaded liposomes of different sizes were prepared and characterized. The pharmaco...

    journal_title:Journal of drug targeting

    pub_type: 杂志文章

    doi:10.1080/10611860801927598

    authors: Sun W,Zou W,Huang G,Li A,Zhang N

    更新日期:2008-06-01 00:00:00

  • Basic fibroblast growth factor-binding peptide as a novel targeting ligand of drug carrier to tumor cells.

    abstract::Drug systems targeting tumor cells using basic fibroblast growth factor (bFGF) have been widely reported. In this study, the peptide KRTGQYKLC (bFGFp), containing cysteine at the carboxyl termination of the bFGF-derived peptide, was applied as a novel ligand targeting tumor cells. bFGFp was conjugated with bovine seru...

    journal_title:Journal of drug targeting

    pub_type: 杂志文章

    doi:10.1080/10611860600849498

    authors: Terada T,Mizobata M,Kawakami S,Yabe Y,Yamashita F,Hashida M

    更新日期:2006-09-01 00:00:00

  • Starch microparticles as oral vaccine adjuvant: antigen-dependent uptake in mouse intestinal mucosa.

    abstract::An oral vaccine formulation comprised of starch microparticles with conjugated antigens is being developed. In this report we have examined the uptake of such microparticles by the intestinal mucosa and examined whether the conjugated antigen can influence the uptake. Two model antigens were used: recombinant cholera ...

    journal_title:Journal of drug targeting

    pub_type: 杂志文章

    doi:10.1080/1061186042000223662

    authors: Larhed A,Stertman L,Edvardsson E,Sjöholm I

    更新日期:2004-06-01 00:00:00

  • Enhanced gene delivery using Bubble liposomes and ultrasound for folate-PEG liposomes.

    abstract::We have previously reported that the transfection efficiency of laminin-derived AG73-peptide labeled polyethyleneglycol-modified liposomes (AG73-PEG liposomes) was enhanced by echo-contrast gas entrapping PEG liposomes (Bubble liposomes, BLs) and ultrasound (US) exposure by improving endosomal escape. However, it has ...

    journal_title:Journal of drug targeting

    pub_type: 杂志文章

    doi:10.3109/1061186X.2012.660162

    authors: Omata D,Negishi Y,Hagiwara S,Yamamura S,Endo-Takahashi Y,Suzuki R,Maruyama K,Aramaki Y

    更新日期:2012-05-01 00:00:00

  • Brain-targeted delivery of paclitaxel using glutathione-coated nanoparticles for brain cancers.

    abstract::Paclitaxel is not effective for treatment of brain cancers because it cannot cross the blood-brain barrier (BBB) due to efflux by P-glycoprotein (P-gp). In this work, glutathione-coated poly-(lactide-co-glycolide) (PLGA) nanoparticles (NPs) of paclitaxel were developed for brain targeting for treatment of brain cancer...

    journal_title:Journal of drug targeting

    pub_type: 杂志文章

    doi:10.3109/1061186X.2011.589435

    authors: Geldenhuys W,Mbimba T,Bui T,Harrison K,Sutariya V

    更新日期:2011-11-01 00:00:00

  • Chloramphenicol-incorporated poly lactide-co-glycolide (PLGA) nanoparticles: formulation, characterization, technetium-99m labeling and biodistribution studies.

    abstract::Chloramphenicol-loaded (CHL) poly-d,l-lactic-co-glycolic acid (PLGA) nanoparticles (NPs) were prepared by emulsification solvent evaporation technique either by using polyvinyl alcohol (PVA) as emulsion stabilizer or polysorbate-80 (PS-80) as surfactant and characterised by transmission electron microscopy, zeta-poten...

    journal_title:Journal of drug targeting

    pub_type: 杂志文章

    doi:10.1080/10611860801899300

    authors: Halder KK,Mandal B,Debnath MC,Bera H,Ghosh LK,Gupta BK

    更新日期:2008-05-01 00:00:00

  • Differences in the adsorption behaviour of poly(ethylene oxide) copolymers onto model polystyrene nanoparticles assessed by isothermal titration microcalorimetry correspond to the biological differences.

    abstract::The adsorption behaviour of a tetrafunctional copolymer of poly (ethylene oxide)-poly (propylene oxide) ethylene diamine (commercially available as Poloxamine 908) and a diblock copolymer of poly (lactic acid)-poly (ethylene oxide) (PLA/PEG 2:5) onto a model colloidal drug carrier (156 nm sized polystyrene latex) is d...

    journal_title:Journal of drug targeting

    pub_type: 杂志文章

    doi:10.1080/10611860500246175

    authors: Stolnik S,Heald CR,Garnett MG,Illum L,Davis SS

    更新日期:2005-09-01 00:00:00

  • Polymersomes as an effective drug delivery system for glioma--a review.

    abstract::Glioma is one of the most commonly occurring malignant brain tumours which need proper treatment strategy. The current therapies for treating glioma like surgical resection, radiotherapy, and chemotherapy have failed in achieving satisfactory results and this forms a rationale for the development of novel drug deliver...

    journal_title:Journal of drug targeting

    pub_type: 杂志文章,评审

    doi:10.3109/1061186X.2014.916712

    authors: Krishnamoorthy B,Karanam V,Chellan VR,Siram K,Natarajan TS,Gregory M

    更新日期:2014-07-01 00:00:00

  • Pieter Cullis: an outstanding lipid biophysicist, drug delivery scientist, educator, and entrepreneur.

    abstract::There are much said about Pieter Cullis in this special volume honoring him. He was the pioneer to study the role of hexagonal HII phase in membrane fusion and the one who applied this concept for the design of lipid nanoparticles. He was also the first to utilize remote loading techniques for the delivery of amphipat...

    journal_title:Journal of drug targeting

    pub_type: 传,历史文章,杂志文章

    doi:10.3109/1061186X.2016.1172590

    authors: Huang L,Miao L

    更新日期:2016-11-01 00:00:00

  • Surface modification of albumin microspheres.

    abstract::Submicron sized hydrophobic and hydrophilic albumin microspheres (MS) were prepared using a chemical crosslinking technique. Spermine was linked to the surface of the hydrophilic MS. The degree of hydrophobicity for these three types of MS was investigated using a novel technique of sedimentation volume. The surface t...

    journal_title:Journal of drug targeting

    pub_type: 杂志文章

    doi:10.3109/10611869509015933

    authors: Shafi ZB,Martin GP,Olliff CJ,James SL

    更新日期:1995-01-01 00:00:00

  • Biphasic interactions between a cationic dendrimer and actin.

    abstract::Gene delivery systems face the problem not only of the route toward the cell and tissues in question, but also of the molecularly crowded environment of both the cytoplasm and the nucleus itself. One of the physical barriers in the cytoplasm for diffusing nanoparticles is an actin network. Here, we describe the findin...

    journal_title:Journal of drug targeting

    pub_type: 杂志文章

    doi:10.3109/1061186X.2010.521159

    authors: Ruenraroengsak P,Florence AT

    更新日期:2010-12-01 00:00:00

  • Targeting tissue factor-expressing tumor angiogenesis and tumors with EF24 conjugated to factor VIIa.

    abstract::Tissue factor (TF) is aberrantly expressed on tumor vascular endothelial cells (VECs) and on cancer cells in many malignant tumors, but not on normal VECs, making it a promising target for cancer therapy. As a transmembrane receptor for coagulation factor VIIa (fVIIa), TF forms a high-affinity complex with its cognate...

    journal_title:Journal of drug targeting

    pub_type: 杂志文章

    doi:10.1080/10611860801890093

    authors: Shoji M,Sun A,Kisiel W,Lu YJ,Shim H,McCarey BE,Nichols C,Parker ET,Pohl J,Mosley CA,Alizadeh AR,Liotta DC,Snyder JP

    更新日期:2008-04-01 00:00:00

  • Tissue distribution and pulmonary targeting studies of cefpiramide sodium-loaded liposomes.

    abstract::The aim of this study was to evaluate the pharmacokinetics (PK), tissue distribution, and the specific drug targeting of cefpiramide sodium-loaded liposomes (CPMS-Lips) compared with cefpiramide sodium solution (CPMS-Sol) in mice. CPMS-Lips were prepared by reverse phase evaporation method. In the PK and biodistributi...

    journal_title:Journal of drug targeting

    pub_type: 杂志文章

    doi:10.3109/10611861003667607

    authors: Sun Q,Shi M,Shao W,Shi Y,Xi Y,Huang G

    更新日期:2011-01-01 00:00:00

  • Targeting of the B-lineage leukemia stem cells and their progeny with norcantharidin encapsulated liposomes modified with a novel CD19 monoclonal antibody 2E8 in vitro.

    abstract::This study was aimed to generate a new agent, norcantharidin (NCTD) encapsulated liposomes modified with a novel murine anti-human CD19 monoclonal antibody 2E8 (2E8–NCTD–liposomes), to specifically target the B-lineage leukemia stem cells (B-LSCs) and their progeny in vitro. Our results have shown that the positive pe...

    journal_title:Journal of drug targeting

    pub_type: 杂志文章

    doi:10.3109/10611861003649720

    authors: Zhang J,Tang Y,Li S,Liao C,Guo X

    更新日期:2010-11-01 00:00:00

  • MAP-mediated nuclear delivery of a cargo protein.

    abstract::Radiolabeled cytochrome c (Cyt c), either as a free protein or as cell penetrating peptide (CPP)-conjugates, was tested for cellular uptake and nuclear transport in Human embryonic kidney 293 (HEK293) cells and HeLa cells. Conjugation of Cyt c with either the amphipathic peptide model amphipathic peptide (MAP) or the ...

    journal_title:Journal of drug targeting

    pub_type: 杂志文章

    doi:10.3109/1061186X.2011.649481

    authors: Kenien R,Zaro JL,Shen WC

    更新日期:2012-05-01 00:00:00

  • Histone deacetylase 9 inhibition upregulates microRNA-92a to repress the progression of intracranial aneurysm via silencing Bcl-2-like protein 11.

    abstract:OBJECTIVE:Histone deacetylases (HDACs) have been revealed to be involved in cerebrovascular diseases, while the role of HDAC9 in intracranial aneurysm (IA) remains seldom studied. We aim to explore the role of the HDAC9/microRNA-92a (miR-92a)/Bcl-2-like protein 11 (BCL2L11) axis in IA progression. METHODS:Expression o...

    journal_title:Journal of drug targeting

    pub_type: 杂志文章

    doi:10.1080/1061186X.2021.1878365

    authors: Cai Y,Huang D,Ma W,Wang M,Qin Q,Jiang Z,Liu M

    更新日期:2021-01-22 00:00:00